SEARCH
Subscribe
Track all markets on TradingView

Calyx Bio-Ventures Stock Takes Off on Blockchain Announcement

Published:

Reading time: 3 min.

Calyx Bio-Ventures Inc. (CVE:CYX) CEO says this first phase is testing ground to streamline its blockchain technology currently being developed for the cannabis e-commerce space

SmallCapPower | December 1, 2017: Calyx Bio-Ventures Inc. (TSXV:CYX) shares surged 100% to $0.36 on Thursday after its wholly-owned subsidiary, Canada Blockchain Hosting Corp, successfully completed the installation and setup of its first cryptocurrency mining and blockchain data validation operation in Kamloops, British Columbia. Calyx Bio-Ventures paid $250,000 for the acquired assets. Vancouver-based Canada Blockchain Hosting is a blockchain computing company. This is the second phase of the Company’s objective to integrate a general cryptocurrency mining facility and distributed computing platform into the Company’s existing blockchain business model.

Win Big With Our Small Cap Picks

 

Calyx Bio-Ventures also owns Cannigistics Agri-Solutions Corp, which is a software development company that has created a software platform originally designed for advanced indoor agriculture, but has now evolved to serve a wider range of industries. Additionally, Calyx Bio-Ventures owns a portfolio of proprietary intellectual property with applications in crop enhancement, as well as messaging software assets.

Calyx Bio-Ventures President & CEO Roger Forde said, “This first phase provides us with a testing ground to streamline our blockchain technology currently being developed for the cannabis e-commerce space, and will generate revenue today that will cover our underlying costs on a month-to-month basis. The Company has sufficient cash in hand to accelerate that plan to the next phase and growth beyond that will be based on opportunities that present themselves.”

Shares of Calyx Bio-Ventures have soared 620% since September 20, 2017, to its current price of $0.36.

This additional computing and hash power will allow the Company to immediately generate additional revenues and significantly enhance the expansion of its private blockchain ecosystem. Calyx Bio-Ventures currently trades at a Price to Book ratio of 25.71x.

Disclosure: Neither the author nor any of the principals at SmallCapPower, or their family members, own shares in the company mentioned above.

To read our full disclosure, please click on the button below:

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
jsteppke
jsteppke

Related articles

Recent articles

© SmallCapPower 2024